Heron Neutron Medical Corp. (7799) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Heron Neutron Medical Corp. (7799:TWSE), powered by AI.

Current Price
$357.00
Sector
Healthcare
What is the Heron Neutron Medical Corp. stock price forecast?

Heron Neutron Medical Corp. is currently trading at $357.00. View real-time AI analysis on Alpha Lenz.

What is Heron Neutron Medical Corp. insider trading activity?

View the latest insider trading data for Heron Neutron Medical Corp. on Alpha Lenz.

What is Heron Neutron Medical Corp.'s P/E ratio?

View Heron Neutron Medical Corp.'s valuation metrics on Alpha Lenz.

Heron Neutron Medical Corp.

TWSE · 7799
NT$357.00+1.50(+0.42%)
Ask about Heron Neutron Medical Corp.'s future dividend policy...
Alpha Chat Insight

Heron Neutron Medical Corp.'s ROE is -7.4%. Explore profitability and growth together.

Ask for details

Company Overview

Heron Neutron Medical Corp. is a healthcare technology company specializing in the development, manufacture, and integration of advanced medical equipment, with a primary focus on accelerator-based boron neutron capture therapy (AB-BNCT) systems. These solutions are designed for precise, effective cancer treatment, leveraging innovations in neutron source targets, accelerators, beam shaping, treatment control, and planning technologies. A distinguishing feature of Heron Neutron Medical Corp. is its position as a comprehensive solution provider: the company not only develops AB-BNCT devices but also integrates boron-containing therapeutic agents, enabling it to offer coordinated device-and-drug solutions to hospitals and research institutions. This integrated approach aims to improve clinical efficiency, enable precision targeting of tumors, lessen side effects compared to conventional treatments, and streamline the patient care process. Founded in 2016 and headquartered in Zhubei, Taiwan, Heron Neutron Medical Corp. continues to shape the market for cancer therapy devices, serving global healthcare providers while advancing the adoption of innovative cancer treatment modalities.

SectorHealthcare
IndustryMedical Devices
Employees60

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$10.31MRevenue
0.00Shares Out
60Employees

Margins

-250.12%Gross
-4279.71%EBITDA
-5183.58%Operating
-4672.74%Pre-Tax
-4672.74%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-7.34%ROA
-7.43%ROE
-7.33%ROIC

Financial Health

NT$2.35BCash & Cash Equivalents
NT$-2.26BNet Debt
0.78%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Heron Neutron Medical Corp. (ticker: 7799) is a company listed on TWSE in the Healthcare sector (Medical Devices). It has approximately 60 employees.

The current price is 357 with a P/E ratio of -x and P/B of -x.

ROE is -7.43% and operating margin is -5183.58%. Annual revenue is $10M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Heron Neutron Medical Corp. (7799) Stock Forecast 2026 $357.00 — Price, Financials & Analyst Targets | Alpha Lenz